Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
₹32 Cr
Revenue (TTM)
₹147 Cr
Net Profit (TTM)
₹-2 Cr
ROE
4.9 %
ROCE
1 %
P/E Ratio
--
P/B Ratio
0.3
Industry P/E
26.42
EV/EBITDA
1157.4
Div. Yield
0 %
Debt to Equity
26.4
Book Value
₹1
EPS
₹-0
Face value
1
Shares outstanding
881,990,132
CFO
₹-1,189.12 Cr
EBITDA
₹45.08 Cr
Net Profit
₹42.16 Cr
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
| -52.0 | -47.1 | -52.0 | -73.0 | -57.2 | 6.6 | -- |
|
BSE Healthcare
| -4.7 | -5.8 | -5.4 | 1.3 | 23.7 | 14.0 | 10.6 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
| -78.8 | -79.5 | 1,895.6 | 1.2 | 192.9 | 111.0 | 35.2 |
|
BSE Small Cap
| -6.6 | 29.0 | 47.5 | -1.8 | 62.8 | 32.1 | -6.8 |
|
BSE Healthcare
| -3.3 | 43.1 | 37.0 | -12.1 | 20.9 | 61.4 | -3.5 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price (₹) | Market Cap (₹ Cr) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Remedium Lifecare
|
0.4 | 31.8 | 146.7 | -2.2 | -9.5 | -3.2 | -- | 0.3 |
| 2,791.2 | 34,920.1 | 5,201.6 | 1,014.6 | 22.9 | 25 | 34.4 | 7.6 | |
| 7,827.5 | 19,544.3 | 2,177.5 | 200.9 | 11.3 | 26.5 | 97.3 | 23.5 | |
| 1,565.8 | 11,917.5 | 2,089.5 | 622.0 | 31.3 | 20.4 | 19.4 | 3.6 | |
| 1,499.2 | 9,167.3 | 1,196.4 | 149.4 | -- | 27.5 | 61.3 | 13.1 | |
| 1,332.1 | 18,429.0 | 3,078.2 | 469.4 | 26.4 | 14.9 | 42.7 | 5.1 | |
| 1,961.1 | 31,410.1 | 4,193.0 | 753.8 | 22.7 | 20.8 | 41.7 | 7.8 | |
| 4,887.1 | 22,333.8 | 2,482.3 | 853.6 | 33.7 | 18.9 | 26.2 | 5.6 | |
| 4,778.6 | 7,918.9 | 1,348.5 | 293.5 | 28.1 | 50.7 | 27 | 11.4 | |
| 971.2 | 8,938.5 | 4,725.6 | 528.7 | 14.9 | 20.7 | 17.5 | 3.0 |
Stock Rating update, March 15, 2024
2 min read•By Value Research
Non-specialized wholesale trade
Incorporated
1988
Chairman
Rambhajan Vishwakarma
Managing Director
--
Headquarters
Mumbai, Maharashtra
Website
Looking for more details about Remedium Lifecare Ltd.’s IPO? Explore our IPO Details page.
Our rating system has guided millions of investors in the past 20 years.
Annual Reports
Announcements
View AnnouncementsSubmission Of Form A - PUBLIC ANNOUNCEMENT
20-Mar-2026Announcement under Regulation 30 (LODR)-Demise
14-Feb-2026
The share price of Remedium Lifecare Ltd is ₹0.36 (BSE) as of 02-Apr-2026 IST. Remedium Lifecare Ltd has given a return of -57.22% in the last 3 years.
Since, TTM earnings of Remedium Lifecare Ltd is negative, P/E ratio is not available.
The P/B ratio of Remedium Lifecare Ltd is 0.35 times as on 02-Apr-2026, a 92 discount to its peers’ median range of 4.48 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
24.06
|
1.67
|
|
2024
|
5.83
|
25.46
|
|
2023
|
1.75
|
25.62
|
|
2022
|
46.26
|
10.10
|
|
2021
|
32.97
|
4.11
|
The 52-week high and low of Remedium Lifecare Ltd are Rs 1.94 and Rs 0.32 as of 02-Apr-2026.
Remedium Lifecare Ltd has a market capitalisation of ₹ 32 Cr as on 02-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in Remedium Lifecare Ltd, assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
₹0.01
(
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.